A BILL TO BE ENTITLED
AN ACT to appropriate funds for a biomonitoring health study for persons in southeastern North carolina impacted by PFAS.
The General Assembly of North Carolina enacts:
SECTION 1.  Study. – The Department of Health and Human Services shall develop and implement a biomonitoring health study program (Program), in consultation with the Department of Environmental Quality, to identify and measure concentrations of toxic chemicals in the population groups within the PFAS Study Area exposed to PFAS chemicals to establish foundational baseline data to support future epidemiological and public health studies and to assess the effectiveness of public health efforts and regulatory programs to decrease exposure to specific toxic chemicals. The Department shall consider epidemiological research completed and in process at academic institutions within the State as well as the Centers for Disease Control and Prevention in designing the Program. For purposes of this section, "PFAS Study Area" means the area within 100 miles of the boundary of the industrial facility located at 22828 North Carolina Highway 87, Fayetteville, North Carolina, and "PFAS chemicals" means per‑ and poly‑fluoroalkyl substances, including GenX.
SECTION 2.  Report. – The Department shall complete the study required by this act no later than December 31, 2022. Until such time, the Task Force shall submit reports every six months to the Environmental Review Commission (ERC), beginning no later than January 1, 2021, on its progress in implementing the requirements of this act, including recommendations for further funding needs.
SECTION 3.  Funding. – The sum of one hundred thousand dollars ($100,000) in nonrecurring funds for the 2020‑2021 fiscal year is appropriated from the General Fund to the Department of Health and Human Services to carry out the Program described in this act.
SECTION 4.  Section 3 of this act becomes effective July 1, 2020. The remainder of this act is effective when it becomes law.